Session 6 - The Cardio-Oncology Team
Details
In this session you will learn more about:
• The role of nurses, pharmacists, and exercise physiologists in the care of cardio-oncology patents
• Strategies to incorporate these professions into your own cardio-oncology practice
• Challenges in developing cardio-oncology practice models for these groups.
Chairs:
Christine Brezden-Masley and Tochukwu Okwuosa
Speakers:
Scott Adams (exercise physiology), Anecita Fadol (nursing), Suzanne McGettigan (nursing), Heather Moore (pharmacy)
Organised by
Date
- America/New_York
Anecita Fadol
Anecita Fadol, PhD, FNP-BC, FAANP, FAAN is an Associate Professor and Education Director, Nursing...
Read MoreAnecita Fadol, PhD, FNP-BC, FAANP, FAAN is an Associate Professor and Education Director, Nursing Cardio-Oncology Program at The University of Texas MD Anderson Cancer Center. Dr. Fadol is a nursing pioneer in the evolving field of cardio-oncology. Her extensive and unique expertise in cardio-oncology have been recognized nationally and internationally. She has written numerous book chapters, published in peer-reviewed journals, and is the editor of the “Cardiac Complications of Cancer Therapy”, the first clinical reference book for nurses that examines the complexity of cardiac problems in conjunction with a cancer diagnosis. Her program of research included the validation of the MD Anderson Symptom Inventory-Heart Failure (MDASI-HF) instrument, which was subsequently translated to Chinese and Spanish. She is on the leadership council for the Cardio-Oncology section of the American College of Cardiology. Dr. Fadol is a fellow of the American Academy of Nurse Practitioners, American Academy of Nursing, and was recently awarded as Honorary Fellow of 2021 by the Hong Kong Academy of Nursing.
Show LessChristine Brezden-Masley
Christine Brezden-Masley, MD PhD FRCPC is a practicing Medical Oncologist and the Director of the...
Read MoreChristine Brezden-Masley, MD PhD FRCPC is a practicing Medical Oncologist and the Director of the Marvelle Koffler Breast Centre at Mount Sinai Hospital as well as the Medical Director of Cancer Program for Sinai Health in Toronto, Canada. She obtained her PhD in Medical Biophysics at the Princess Margaret Hospital in Toronto and her Medical Degree from the University of Toronto. She is currently an Associate Professor at the University of Toronto and senior scientist for the same Clinical Research Group at the Lunenfeld-Tanenbaum Research Institute for Sinai Health System in Toronto, Canada. Dr Brezden-Masley is the founder of the COMET (Community Oncologists of Metropolitan Toronto) Clinical Trials Consortium, a web-based virtual network promoting cancer clinical trials throughout the Toronto region. She treats both breast and gastrointestinal (colorectal and gastric cancers) malignancies, which are her major areas of research interest. Her main area of clinical research is cardiotoxicity from cancer therapy and is currently the President of the Canadian Cardio-Oncology Network. She is also on the Board of Directors of ReThink Breast Cancer, a national advocacy and support network for young women with breast cancer and My Gut Feeling, a stomach cancer support network for patients, survivors, and caregivers.
Show LessHeather Moore
Dr. Moore is originally from eastern North Carolina. She completed her undergraduate degree in...
Read MoreDr. Moore is originally from eastern North Carolina. She completed her undergraduate degree in biology at North Carolina State University and received her doctorate of pharmacy at the UNC Eshelman School of Pharmacy in Chapel Hill. She completed her general residency training at the Durham Veterans Affairs Hospital where she realized her passion for oncology and then continued on to complete oncology residency training at VCU hospital in Richmond, Virginia. After residency, she decided to return home to North Carolina and accepted a position in the breast oncology clinic at the Duke Cancer Institute. She has developed a specific interest in cardio oncology given the cardiotoxicity seen with many breast cancer therapies which led to involvement within the cardio oncology program at Duke. In her free time, she enjoys reading, playing tennis, supporting NC State athletics and spending time with her dog, Chauncey.
Show LessScott Adams
Dr Scott Adams is an Assistant Scientist (Toronto General Hospital Research Institute, University...
Read MoreDr Scott Adams is an Assistant Scientist (Toronto General Hospital Research Institute, University Health Network [UHN]) and the Exercise Lead (Ted Rogers Cardiotoxicity Prevention Program, UHN). He is the Director of the ‘Research in Exercise & Cardiorespiratory Health in Oncology’ laboratory (UHN) and a member of the Adolescent and Young Adult Oncology Program (Princess Margaret Cancer Centre) and the Cardiovascular Prevention and Rehabilitation Program (Toronto Rehab Institute). He completed his PhD at the University of Alberta and two post-doctoral fellowships at Memorial Sloan Kettering Cancer Center and the University of Toronto. His research adopts precision medicine and knowledge translation approaches to (1) phenotype cancer patients and survivors using complementary cardiovascular profiling tools (e.g. cardiopulmonary exercise testing, vascular imaging, autonomic function assessments) to augment cardiovascular risk screening and stratification, (2) develop targeted exercise-based multi-modal therapies that target the discrete mechanisms of risk and injury within these phenotype-defined groups, and (3) facilitate the translation of this and related research into practice.
Show LessSuzanne McGettigan
Suzanne McGettigan, MSN, CRNP, ANP-BC, AOCN is an Oncology Nurse Practitioner and Clinical...
Read MoreSuzanne McGettigan, MSN, CRNP, ANP-BC, AOCN is an Oncology Nurse Practitioner and Clinical Manager of Advanced Practice Providers and Nursing, at the Abramson Cancer Center at the University of Pennsylvania, in the Division of Hematology-Oncology. She has been a part of the Melanoma and Cutaneous Malignancies Program since 2005 as well as other disease based specialties within the Division. She also is a Clinical Associate at the University of Pennsylvania, School of Nursing, in the graduate Nurse Practitioner program. Through her clinical work, Ms. McGettigan has provided care to patients receiving immunotherapy, targeted therapy, and chemotherapy as well as symptom management and survivorship care to cancer patients. She has been a sub-investigator on a number of therapeutic clinical trials. She has published articles in peer reviewed journals detailing nursing and APP care of patients and provided lectures nationally on these topics. After graduating from Washington and Lee University with a Bachelor of Science in Biology, Ms. McGettigan earned both her Bachelor of Science and Master of Science in Nursing from the University of Pennsylvania. Ms. McGettigan holds certification as an Advanced Oncology Nurse and an Adult Nurse Practitioner. She is an active member of the Oncology Nursing Society, the Advanced Practitioner Society for Hematology Oncology, and the Society of Immunotherapy for Cancer.
Show LessTochukwu Okwuosa
Dr. Tochukwu Okwuosa is a cardiologist, Associate Professor of Internal Medicine and the Director...
Read MoreDr. Tochukwu Okwuosa is a cardiologist, Associate Professor of Internal Medicine and the Director of Cardio-Oncology Services at Rush University Medical Center (RUMC). Dr. Okwuosa’s research focuses on identification and prevention of cancer therapy-induced cardiotoxicity. She has received the Cohn’s research award to study markers of cardiotoxicity in breast cancer patients post chemotherapy and the Piccolo-Gavers Translational Research Grant Award for evaluating markers of doxorubicin-induced cardiotoxicity. Okwuosa has also published many peer-reviewed research articles, review articles and editorials in the field of cardio-oncology, including in the Journal of the American College of Cardiology and JAMA. Dr. Okwuosa has spearheaded a number of successful cardio-oncology initiatives at Rush and regionally including the biennial Midwest regional Cardio-Oncology symposium geared toward educating general practitioners involved in the cardiac care of cancer; the triannual Chicago City-wide Cardio-oncology Rounds (CCCR) involving all the major eight Chicago academic institutions; and the biannual Cardio-Oncology patient education seminar series aimed at increasing awareness of and proactiveness in cardiovascular diseases in cancer survivors. She was invited to sit on the Metro Chicago Board for the American Heart Association and is the recipient of numerous awards including Teacher of Year Award for Internal Medicine Residents 2020. She sits on national cardio-oncology committees and writing groups with the American College of Cardiology and the American Heart Association (AHA); is the Vice Chair of the Cardio-Oncology subcommittee for the AHA; and is regionally, nationally and internationally recognized as an expert in cardio-oncology.
Show Less